Els M Gielis1, Kristien J Ledeganck1, Amélie Dendooven2, Pieter Meysman3,4, Charlie Beirnaert3,4, Kris Laukens3,4, Joachim De Schrijver5, Steven Van Laecke6, Wim Van Biesen6, Marie-Paule Emonds7, Benedicte Y De Winter1, Jean-Louis Bosmans1,8, Jurgen Del Favero5, Daniel Abramowicz1,8. 1. Laboratory of Experimental Medicine and Pediatrics, University of Antwerp, Antwerp, Belgium. 2. Department of Pathology, Antwerp University Hospital, Antwerp, Belgium. 3. Biomedical Informatics Research Network Antwerp (Biomina), University of Antwerp/Antwerp University Hospital, Antwerp, Belgium. 4. Advanced Database Research and Modelling (ADReM), Department of Mathematics and Computer Science, University of Antwerp, Antwerp, Belgium. 5. Multiplicom N.V., part of Agilent Technologies, Niel, Belgium. 6. Department of Nephrology, Renal Division, Ghent University Hospital, Ghent, Belgium. 7. Histocompatibility and Immunogenetic Laboratory, Belgian Red Cross Flanders, Mechelen, Belgium. 8. Department of Nephrology and Hypertension, Antwerp University Hospital, Antwerp, Belgium.
Abstract
BACKGROUND: After transplantation, cell-free deoxyribonucleic acid (DNA) derived from the donor organ (ddcfDNA) can be detected in the recipient's circulation. We aimed to investigate the role of plasma ddcfDNA as biomarker for acute kidney rejection. METHODS: From 107 kidney transplant recipients, plasma samples were collected longitudinally after transplantation (Day 1 to 3 months) within a multicentre set-up. Cell-free DNA from the donor was quantified in plasma as a fraction of the total cell-free DNA by next generation sequencing using a targeted, multiplex polymerase chain reaction-based method for the analysis of single nucleotide polymorphisms. RESULTS: Increases of the ddcfDNA% above a threshold value of 0.88% were significantly associated with the occurrence of episodes of acute rejection (P = 0.017), acute tubular necrosis (P = 0.011) and acute pyelonephritis (P = 0.032). A receiver operating characteristic curve analysis revealed an equal area under the curve of the ddcfDNA% and serum creatinine of 0.64 for the diagnosis of acute rejection. CONCLUSIONS: Although increases in plasma ddcfDNA% are associated with graft injury, plasma ddcfDNA does not outperform the diagnostic capacity of the serum creatinine in the diagnosis of acute rejection.
BACKGROUND: After transplantation, cell-free deoxyribonucleic acid (DNA) derived from the donor organ (ddcfDNA) can be detected in the recipient's circulation. We aimed to investigate the role of plasma ddcfDNA as biomarker for acute kidney rejection. METHODS: From 107 kidney transplant recipients, plasma samples were collected longitudinally after transplantation (Day 1 to 3 months) within a multicentre set-up. Cell-free DNA from the donor was quantified in plasma as a fraction of the total cell-free DNA by next generation sequencing using a targeted, multiplex polymerase chain reaction-based method for the analysis of single nucleotide polymorphisms. RESULTS: Increases of the ddcfDNA% above a threshold value of 0.88% were significantly associated with the occurrence of episodes of acute rejection (P = 0.017), acute tubular necrosis (P = 0.011) and acute pyelonephritis (P = 0.032). A receiver operating characteristic curve analysis revealed an equal area under the curve of the ddcfDNA% and serum creatinine of 0.64 for the diagnosis of acute rejection. CONCLUSIONS: Although increases in plasma ddcfDNA% are associated with graft injury, plasma ddcfDNA does not outperform the diagnostic capacity of the serum creatinine in the diagnosis of acute rejection.
Authors: Michael Oellerich; Karen Sherwood; Paul Keown; Ekkehard Schütz; Julia Beck; Johannes Stegbauer; Lars Christian Rump; Philip D Walson Journal: Nat Rev Nephrol Date: 2021-05-24 Impact factor: 28.314
Authors: Daniela Gerges-Knafl; Peter Pichler; Alexander Zimprich; Christoph Hotzy; Wolfgang Barousch; Rita M Lang; Elisabeth Lobmeyr; Sabina Baumgartner-Parzer; Ludwig Wagner; Wolfgang Winnicki Journal: BMC Nephrol Date: 2020-04-06 Impact factor: 2.388
Authors: Jeroen G H P Verhoeven; Carla C Baan; Annemiek M A Peeters; Marian C Clahsen-van Groningen; Daan Nieboer; Mariëlle Herzog; Marc Eccleston; Dennis A Hesselink; Karin Boer Journal: Clin Epigenetics Date: 2021-02-11 Impact factor: 6.551